Abstract
The aim of this study was to investigate intensity of free radical processes and catalase activity in serum of patients with thyrotoxicosis during traditional therapy and combined therapy with epifamin. Patients (n = 25) were subdivided into two groups: the first group of patients (n = 12) received traditional therapy (antithyroid drugs, β-adrenoblockers, and the second group of patients (n = 13) received additionally epifamin (1 tablet of 10 mg 3 times a day, 10–15 minutes before meal for 7 days). The thyrotoxic patients were characterized by intensification of free radical oxidation evaluated in blood serum by biochemiluminescence parameters. During the combined therapy with epifamin there was less expressed intensity of free-radical processes and the increase in total antioxidant activity of the body, which was not observed during traditional therapy. The standard therapy of thyrotoxicosis by thyrostatics and β-adrenoblockers decreased catalase activity and thus exhibited a negative effect on the antioxidant status of the body. On the contrary, combined therapy with epifamin increased catalase activity and this could positively influence the antioxidant protection of the body.
Similar content being viewed by others
References
Rodrigyez-Gomez, I., Wangensteen, R., and Moreno, J.M., Am. J. Physiol. Endocrinol. Metab., 2005, vol. 288, pp. E1252–E1257.
Fernandes, V. and Videla, L.A., in Handbook of Free Radicals and Antioxidants in Biomedicine, Miquel, J., Quintanilha, A.T., and Weber, H., Eds, Boca Raton: CRC Press Inc, 1989, pp. 105–115.
Kutsenko, S.A., Osnovy toksikologii (Principles of Toxicology), St-Petersburg, 2002.
Mayo, J.C., Tan, D.X., and Sainz, R.M., Free Radic. Res., 2003, vol. 37, pp. 543–553.
Popov, S.S., Pashkov, A.N., Popova, T.N., Zoloedov, V.I., Semenikhina, A.V., and Rakhmanova, T.I., Biomed. Khim., 2008, vol. 54, pp. 83–87.
Bondarenko, L.A., Anisimov, V.N., Khavinson, V.Kh., Abstr. Int. Symp. Gerontologic Aspects of Peptide Regulation of Organism Functions, St-Petersburg, 1996, pp. 27–28.
Khavinson, V. Kh. and Shutak, T.S., Primenenie epitalamina pri insulinnezavisimom sakharnom diabete (Application of Epitalamin for Treatment of Insulin-Independent Diabetes Mellitus), St-Petersburg: Foliant, 2000.
Lowry, O.H., Rosebrough, N., Farr, A., and Randall, R., J. Biol. Chem., 1951, vol. 193, pp. 265–275.
Castilho, R.F., Kowaltowski, A.J., and Vercesi, A.E., Arch. Biochem. Biophys., 1989, vol. 354, pp. 151–157.
Popov, S.S., Pashkov, A.N., Popova, T.N., Zoloedov, V.I., Semenikhina, A.V., and Rakhmanova, T.I., Byul. Eksper. Biol. Med., 2007, no. 8, pp. 170–173.
Ivashkin, V.T. and Maevskaya, M.V., Alkogol’no-virusnye zabolevaniya pecheni (Alcohol and Viral Liver Diseases), Moscow: Litterra, 2007.
Seymen, O., Seven, A., and Hatemi, S., Med. Sci. Res., 1995, vol. 23, pp. 695–696.
Pang, S.F., Ayre, E.A., and Pang, C.S., J. Chem. Neuroanat., 1998, vol. 14, nos. 3–4, pp. 157–166.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.S. Popov, A.N. Pashkov, V.I. Zoloedov, T.N. Popova, T.I. Rakhmanova, 2010, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Popov, S.S., Pashkov, A.N., Zoloedov, V.I. et al. The antioxidant status of patients with thyrotoxicosis during combined therapy with epifamin. Biochem. Moscow Suppl. Ser. B 4, 400–403 (2010). https://doi.org/10.1134/S199075081004013X
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S199075081004013X